132 related articles for article (PubMed ID: 15737573)
1. The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development.
Sabbattini P; Dillon N
Semin Immunol; 2005 Apr; 17(2):121-7. PubMed ID: 15737573
[TBL] [Abstract][Full Text] [Related]
2. Mapping and functional analysis of regulatory sequences in the mouse lambda5-VpreB1 domain.
Minaee S; Farmer D; Georgiou A; Sabbattini P; Webster Z; Chow CM; Dillon N
Mol Immunol; 2005 Jul; 42(11):1283-92. PubMed ID: 15950724
[TBL] [Abstract][Full Text] [Related]
3. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
[TBL] [Abstract][Full Text] [Related]
4. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
Licence S; Persson C; Mundt C; Mårtensson IL
Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
[TBL] [Abstract][Full Text] [Related]
5. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.
Okabe T; Bauer SR; Kudo A
Eur J Immunol; 1992 Jan; 22(1):31-6. PubMed ID: 1730257
[TBL] [Abstract][Full Text] [Related]
6. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
[TBL] [Abstract][Full Text] [Related]
7. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
van Loo PF; Dingjan GM; Maas A; Hendriks RW
Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
[TBL] [Abstract][Full Text] [Related]
8. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
[TBL] [Abstract][Full Text] [Related]
9. Early B cell factor binds to a site critical for lambda5 core enhancer activity.
Mårtensson A; Mårtensson IL
Eur J Immunol; 1997 Jan; 27(1):315-20. PubMed ID: 9022034
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin inhibition of E2A stops expression of surrogate light chains of the pre-B-cell receptor and CD19.
Hauser J; Wallenius A; Sveshnikova N; Saarikettu J; Grundström T
Mol Immunol; 2010 Feb; 47(5):1031-8. PubMed ID: 20022378
[TBL] [Abstract][Full Text] [Related]
11. Gene conversion events contribute to the polymorphic variation of the surrogate light chain gene lambda 5/14.1.
Conley ME; Rapalus L; Boylin EC; Rohrer J; Minegishi Y
Clin Immunol; 1999 Nov; 93(2):162-7. PubMed ID: 10527692
[TBL] [Abstract][Full Text] [Related]
12. Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment.
Sherwood EM; Blomberg BB; Xu W; Warner CA; Riley RL
J Immunol; 1998 Nov; 161(9):4472-5. PubMed ID: 9794368
[TBL] [Abstract][Full Text] [Related]
13. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes.
Sigvardsson M; O'Riordan M; Grosschedl R
Immunity; 1997 Jul; 7(1):25-36. PubMed ID: 9252117
[TBL] [Abstract][Full Text] [Related]
14. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins.
Sherwood EM; Xu W; King AM; Blomberg BB; Riley RL
Mech Ageing Dev; 2000 Sep; 118(1-2):45-59. PubMed ID: 10989124
[TBL] [Abstract][Full Text] [Related]
15. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter.
Sigvardsson M
Mol Cell Biol; 2000 May; 20(10):3640-54. PubMed ID: 10779354
[TBL] [Abstract][Full Text] [Related]
16. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mice with single and multiple copies of transgenes reveals a novel arrangement for the lambda5-VpreB1 locus control region.
Sabbattini P; Georgiou A; Sinclair C; Dillon N
Mol Cell Biol; 1999 Jan; 19(1):671-9. PubMed ID: 9858590
[TBL] [Abstract][Full Text] [Related]
18. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.
Sabbattini P; Lundgren M; Georgiou A; Chow C; Warnes G; Dillon N
EMBO J; 2001 Jun; 20(11):2812-22. PubMed ID: 11387214
[TBL] [Abstract][Full Text] [Related]
19. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription.
Parker MJ; Licence S; Erlandsson L; Galler GR; Chakalova L; Osborne CS; Morgan G; Fraser P; Jumaa H; Winkler TH; Skok J; Mårtensson IL
EMBO J; 2005 Nov; 24(22):3895-905. PubMed ID: 16281060
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain.
Minegishi Y; Hendershot LM; Conley ME
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3041-6. PubMed ID: 10077633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]